These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10369989)

  • 41. Correlation between apparent diffusion coefficient and histopathology subtypes of osteosarcoma after neoadjuvant chemotherapy.
    Wang J; Sun M; Liu D; Hu X; Pui MH; Meng Q; Gao Z
    Acta Radiol; 2017 Aug; 58(8):971-976. PubMed ID: 27852643
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tl-201 and Tc-99m HMDP scintigraphic findings in extraskeletal osteosarcoma.
    Kajihara M; Sugawara Y; Miki H; Mochizuki T; Kidani T; Sakayama K
    Clin Nucl Med; 2005 May; 30(5):356-8. PubMed ID: 15827415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [High dosage Gd-DPTA-BMA (Gadodiamid) administration in diagnosis and therapeutic monitoring of malignant bone tumors].
    Häussler MD; Rummeny EJ; Raufhake C; Blasius S; Lindner N; Daldrup HE; Reimer P; Peters PE
    Radiologe; 1996 Feb; 36(2):148-52. PubMed ID: 8867432
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Paget disease and osteosarcoma of the calcaneus.
    de Waele S; Lonneux M; Vande Berg B; Nzeusseu A; Brasseur JP; Lecouvet FE
    Clin Nucl Med; 2001 Mar; 26(3):244-6. PubMed ID: 11245124
    [No Abstract]   [Full Text] [Related]  

  • 45. Bone-seeking radiopharmaceuticals as targeted agents of osteosarcoma: samarium-153-EDTMP and radium-223.
    Anderson PM; Subbiah V; Rohren E
    Adv Exp Med Biol; 2014; 804():291-304. PubMed ID: 24924181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of MRI in osteosarcoma for evaluation and prediction of chemotherapy response: correlation with histological necrosis.
    Bajpai J; Gamnagatti S; Kumar R; Sreenivas V; Sharma MC; Khan SA; Rastogi S; Malhotra A; Safaya R; Bakhshi S
    Pediatr Radiol; 2011 Apr; 41(4):441-50. PubMed ID: 20978754
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Application of the alteration uptake ratio of
    Huang Z; Lou C
    Hell J Nucl Med; 2018; 21(1):55-59. PubMed ID: 29705817
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diffusion-weighted imaging in differentiating mid-course responders to chemotherapy for long-bone osteosarcoma compared to the histologic response: an update.
    Habre C; Dabadie A; Loundou AD; Banos JB; Desvignes C; Pico H; Aschero A; Colavolpe N; Seiler C; Bouvier C; Peltier E; Gentet JC; Baunin C; Auquier P; Petit P
    Pediatr Radiol; 2021 Aug; 51(9):1714-1723. PubMed ID: 33877417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative (201)thallium scintigraphy for prediction of histological response to neoadjuvant chemotherapy in osteosarcoma; systematic review and meta-analysis.
    Kubo T; Shimose S; Fujimori J; Furuta T; Ochi M
    Surg Oncol; 2015 Sep; 24(3):194-9. PubMed ID: 26092710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MRI for evaluation of preoperative chemotherapy in osteosarcoma.
    Yildirim O; Al Khatalin M; Kargin OA; Camurdan VB
    Radiography (Lond); 2022 Aug; 28(3):593-604. PubMed ID: 35537246
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A single (99m)Tc-MIBI study to predict response to neoadjuvant treatment in sarcoma patiens.
    Sohaib M; Wiqar MA; Ali MK; Hussain F; Umer-i-Farooq
    Hell J Nucl Med; 2011; 14(2):140-5. PubMed ID: 21761016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma.
    Franzius C; Bielack S; Flege S; Sciuk J; Jürgens H; Schober O
    J Nucl Med; 2002 Aug; 43(8):1012-7. PubMed ID: 12163625
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Osteoblastic osteosarcoma of the mandible: findings on Tc-99m HMDP bone and Ga-67 citrate scintigraphy.
    Takahashi T; Oguchi M; Kuga G; Higashi K; Tonami H; Yamamoto I; Segami N; Nojima T
    Clin Nucl Med; 2005 Sep; 30(9):608-9. PubMed ID: 16100479
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlation of histopathology and multi-modal magnetic resonance imaging in childhood osteosarcoma: Predicting tumor response to chemotherapy.
    Teo KY; Daescu O; Cederberg K; Sengupta A; Leavey PJ
    PLoS One; 2022; 17(2):e0259564. PubMed ID: 35157711
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Value of thallium-201 scintigraphy in assessment of neoadjuvant chemotherapy for osteosarcoma].
    Huang ZK; Lou C; Fang XQ
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):769-72. PubMed ID: 20021831
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Imaging assessment of the responses of osteosarcoma patients to preoperative chemotherapy: angiography compared with thallium-201 scintigraphy.
    Kunisada T; Ozaki T; Kawai A; Sugihara S; Taguchi K; Inoue H
    Cancer; 1999 Sep; 86(6):949-56. PubMed ID: 10491520
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tc-99m MDP bone scintigraphy in a patient with multicentric osteosarcoma.
    Cermik TF; Salan A; Firat MF; Berkarda S
    Clin Nucl Med; 2003 Jul; 28(7):599-600. PubMed ID: 12819421
    [No Abstract]   [Full Text] [Related]  

  • 58. Osteosarcoma: chemotherapy-induced changes at MR imaging.
    Holscher HC; Bloem JL; Vanel D; Hermans J; Nooy MA; Taminiau AH; Henry-Amar M
    Radiology; 1992 Mar; 182(3):839-44. PubMed ID: 1535905
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factor analysis of dynamic magnetic resonance imaging in predicting the response of osteosarcoma to chemotherapy.
    Bonnerot V; Charpentier A; Frouin F; Kalifa C; Vanel D; Di Paola R
    Invest Radiol; 1992 Oct; 27(10):847-55. PubMed ID: 1399442
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spectrum of technetium-99m methylene diphosphonate (99mTc MDP) uptake in Osteosarcoma.
    Gill SM; Mufty S; Hassan A
    J Pak Med Assoc; 2023 Jul; 73(7):1551-1552. PubMed ID: 37469083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.